This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a trifluoromethoxy group, is particularly valuable in the development of drugs targeting the central nervous system (CNS), such as antidepressants, antipsychotics, and anxiolytics. The trifluoromethoxy moiety enhances the compound's ability to cross the blood-brain barrier, improving its efficacy in CNS-related applications. Additionally, it is employed in organic synthesis to create novel compounds with potential therapeutic properties, particularly in the field of medicinal chemistry. Its chiral nature also makes it useful in the production of enantiomerically pure drugs, which can lead to improved drug safety and efficacy.